To further evaluate the clinical value of MBNL1-AS1 in the analysis of the PRAD samples in the TCGA-PRAD cohort, clinical characteristics were screened by univariate and multivariate Cox regression. Here, MBNL1 is linked to prostate adenocarcinoma.